EIKONOKLASTES THERAPEUTICS

eikonoklastes-therapeutics-logo

Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered that certain pathological cells – but not healthy cells – including cancers with high unmet need and high mortality such as triple-negative breast cancer, ovarian cancer, metastatic melanoma, and a broad range of other solid tumors, express tissue factor on the surface of their cell membranes. Several other non-cancerous indications such as endometriosis also highly and selectively express tissue factor.

#SimilarOrganizations #People #Financial #Website #More

EIKONOKLASTES THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Life Science

Founded:
2019-01-01

Address:
Cincinnati, Ohio, United States

Country:
United States

Website Url:
http://www.eikonoklastes.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
5.98 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

umoja-biopharma-logo

Umoja Biopharma

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Current Employees Featured

mark-dato_image

Mark Dato
Mark Dato Chief Scientific Officer and Chief Medical Officer @ Eikonoklastes Therapeutics
Chief Scientific Officer and Chief Medical Officer
2019-11-01

samuel-lee_image

Samuel Lee
Samuel Lee Co-Founder and Chief Business Officer @ Eikonoklastes Therapeutics
Co-Founder and Chief Business Officer
2019-01-01

bruce-halpryn_image

Bruce Halpryn
Bruce Halpryn Cofounder, Chief Executive Officer and President @ Eikonoklastes Therapeutics
Cofounder, Chief Executive Officer and President
2019-03-01

Founder


bruce-halpryn_image

Bruce Halpryn

samuel-lee_image

Samuel Lee

Investors List

techcolumbus-2_image

Rev1 Ventures

Rev1 Ventures investment in Series A - Eikonoklastes Therapeutics

jobsohio_image

JobsOhio

JobsOhio investment in Series A - Eikonoklastes Therapeutics

elk-capital-ventures_image

Elk Capital Ventures

Elk Capital Ventures investment in Series A - Eikonoklastes Therapeutics

cincytech_image

CincyTech

CincyTech investment in Series A - Eikonoklastes Therapeutics

cincytech_image

CincyTech

CincyTech investment in Seed Round - Eikonoklastes Therapeutics

Official Site Inspections

http://www.eikonoklastes.com

  • Host name: 4.139.71.34.bc.googleusercontent.com
  • IP address: 34.71.139.4
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Eikonoklastes Therapeutics" on Search Engine